Earnings History Data for Mainz Biomed NV (MYNZ) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mainz Biomed NV

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
16-11-2023 PM MYNZ Mainz Biomed NV 15.00 -0.39 -0.50 0.00 Mainz Biomed B.V. GAAP EPS of -$0.39, revenue of $181.66M
[11/16/2023 10:40 AM]
1.15 -0.06 
(-4.96%)
1.22 0.01 
(0.83%)
1.05 - 9.61 261,103 360,000 1,967
16-05-2023 PM MYNZ Mainz Biomed NV 62.00 -0.45 -0.47 0.00 Mainz Biomed B.V. GAAP EPS of -$0.45 beats by $0.02, revenue of $0.25M misses by $0.04M
[5/16/2023 3:21 AM]
5.37 -0.12 
(-2.19%)
0.0 0.0 
(0.00%)
3.18 - 12.40 21,059 60,000 0